Additionally, functional annotation further suggested that CD3E, CD3D, and LCK were involved in positive regulation of T cell activation and leukocyte cell-cell adhesion that were known as the chief determinant for the efficacy of tumor immunotherapy (Ding and Chen, 2019; Alvarez et al., 2020). The gene discussed is LCK; the disease is neoplasm.